Metastatic renal cell carcinoma: Which Medications Are Safest? (137 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
137 medications are used for Metastatic renal cell carcinoma, with 13,743 combined adverse event reports. The most reported drugs for Metastatic renal cell carcinoma are SUNITINIB MALATE and NIVOLUMAB.
13,743
Total Reports
137
Drugs Used
All Medications for Metastatic renal cell carcinoma Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| SUNITINIB MALATE | Sunitinib malate | 4,271 | 6,028 | 5,720 | 27.9% |
| NIVOLUMAB | OPDIVO | 3,857 | 23,086 | 36,530 | 26.3% |
| IPILIMUMAB | YERVOY | 1,826 | 8,043 | 17,031 | 22.0% |
| AXITINIB | INLYTA | 1,612 | 3,141 | 4,050 | 19.8% |
| PAZOPANIB | Pazopanib | 1,353 | 5,612 | 4,347 | 26.5% |
| CABOZANTINIB S-MALATE | CABOMETYX | 1,055 | 4,203 | 6,193 | 10.7% |
| EVEROLIMUS | EVEROLIMUS | 653 | 8,374 | 11,211 | 21.1% |
| PEMBROLIZUMAB | KEYTRUDA | 534 | 15,543 | 35,472 | 18.6% |
| LENVATINIB | Lenvima | 343 | 4,449 | 19,975 | 13.2% |
| CABOZANTINIB | - | 292 | 767 | 2,771 | 20.0% |
| SUNITINIB | - | 229 | 306 | 430 | 17.2% |
| BEVACIZUMAB | JOBEVNE | 216 | 17,498 | 23,114 | 22.4% |
| AVELUMAB | BAVENCIO | 170 | 861 | 1,630 | 23.7% |
| SUTENT | - | 157 | 386 | 259 | 32.2% |
| SORAFENIB | sorafenib | 134 | 2,489 | 3,547 | 22.8% |
| TEMSIROLIMUS | Temsirolimus | 131 | 361 | 727 | 21.9% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 115 | 8,520 | 15,094 | 25.3% |
| TIVOZANIB | FOTIVDA | 49 | 135 | 291 | 9.7% |
| INLYTA | - | 46 | 113 | 75 | 22.3% |
| INTERFERON ALFA-2A | - | 45 | 83 | 171 | 14.0% |